Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers

BACKGROUND: Lung cancers account for the majority of brain metastases which pose major therapeutic challenges. Biomarkers prognosticating for the development of brain metastases in patients with non-small cell lung cancers (NSCLC) may improve personalized care. Six serum proteomic biomarkers were pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bob T., Lou, Emil, Hsu, Meier, Yu, Helena A., Naidoo, Jarushka, Zauderer, Marjorie G., Sima, Camelia, Johnson, Melissa L., Daras, Mariza, DeAngelis, Lisa M., Fleisher, Martin, Kris, Mark G., Azzoli, Christopher G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701719/
https://www.ncbi.nlm.nih.gov/pubmed/26730601
http://dx.doi.org/10.1371/journal.pone.0146063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701719/
https://www.ncbi.nlm.nih.gov/pubmed/26730601
http://dx.doi.org/10.1371/journal.pone.0146063

Ejemplares similares